Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas. 2009

Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
Basic Research Laboratory, Laboratory of Pathology, Dermatology Branch, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

To look for a direct role of ultraviolet radiation (UV) exposure in cutaneous melanoma induction, we studied xeroderma pigmentosum (XP) patients who have defective DNA repair resulting in a 1000-fold increase in melanoma risk. These XP melanomas have the same anatomic distribution as melanomas in the general population. We analyzed laser capture microdissection samples of skin melanomas from XP patients studied at the National Institutes of Health. The tumor suppressor gene PTEN was sequenced and analyzed for UV-induced mutations. Samples from 59 melanomas (47 melanomas in situ and 12 invasive melanomas) from 8 XP patients showed mutations in the PTEN tumor suppressor gene in 56% of the melanomas. Further, 91% of the melanomas with mutations had 1 to 4 UV type base substitution mutations (occurring at adjacent pyrimidines) (P < 0.0001 compared to random mutations). We found a high frequency of amino-acid-altering mutations in the melanomas and demonstrated that these mutations impaired PTEN function; UV damage plays a direct role in induction of mutations and in inactivation of the PTEN gene in XP melanomas including in situ, the earliest stage of melanoma. This gene is known to be a key regulator of carcinogenesis and therefore these data provide solid mechanistic support for UV protection for prevention of melanoma.

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D014983 Xeroderma Pigmentosum A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA. Kaposi Disease,Kaposi's Disease,Kaposis Disease
D051059 PTEN Phosphohydrolase A lipid phosphatase that contains a C2 DOMAIN and acts on phosphatidylinositol-3,4,5-trisphosphate to regulate various SIGNAL TRANSDUCTION PATHWAYS. It modulates CELL GROWTH PROCESSES; CELL MIGRATION; and APOPTOSIS. Mutations in PTEN are associated with COWDEN DISEASE and PROTEUS SYNDROME as well as NEOPLASTIC CELL TRANSFORMATION. MMAC1 Protein,Mutated In Multiple Advanced Cancers 1 Protein,PTEN Phosphatase,PTEN Protein,PTEN Protein Phosphatase,Phosphatase and Tensin Homologue on Chromosome Ten Protein,Phosphatase, PTEN,Phosphatase, PTEN Protein,Phosphohydrolase, PTEN,Protein Phosphatase, PTEN

Related Publications

Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
September 1993, The British journal of ophthalmology,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
June 2010, The Journal of investigative dermatology,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
January 1991, Journal of molecular biology,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
December 1994, The American Journal of dermatopathology,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
July 1993, Cancer research,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
August 1984, Journal of the American Academy of Dermatology,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
January 1986, Annales de dermatologie et de venereologie,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
May 1971, The Journal of laboratory and clinical medicine,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
October 1950, The British journal of dermatology and syphilis,
Yun Wang, and John J Digiovanna, and Jere B Stern, and Thomas J Hornyak, and Mark Raffeld, and Sikandar G Khan, and Kyu-Seon Oh, and M Christine Hollander, and Philip A Dennis, and Kenneth H Kraemer
December 2004, Gene therapy,
Copied contents to your clipboard!